Jakubowitz Law
Business Minds. Legal Insight.

We combine large firm expertise with small firm attention. Our clients can expect the best results and the most personal experience.

Jakubowitz Law IS HERE TO HELP SHAREHOLDERS WHO PURCHASED Teladoc Health, Inc. (TDOC)

According to the complaint, on February 20, 2024, Teladoc announced its fourth quarter and full year results for the period ended December 31, 2023. The announcement disclosed that Teladoc had experienced substantially less growth than previous forecasted. The Company also disclosed that it was expecting decreased revenue for its BetterHelp segment, an online counseling service. Analysts attributed this trend to BetterHelp’s market saturation and increased advertising costs causing a rise the cost of customer acquisitions. Following the release of the earnings report, TDOC shares fell $4.85/share, or 23.6%, overnight.

If you incurred a loss on TDOC stock purchased between November 2, 2022 and February 20, 2024, this lawsuit is on your behalf. The lawsuit was filed in , and our firm is reaching out to investors to discuss their legal rights.

If you wish to act as a representative of the shareholders harmed by this misconduct, you may ask the court to appoint you as lead plaintiff. A lead plaintiff directs the litigation and participates in important decisions, including whether to accept a settlement for the class in the action.

You only have until July 16, 2024 to apply to be lead plaintiff. The court will then evaluate the applicants and choose a lead plaintiff. You are not required to act as a lead plaintiff in order to participate in any recovery.

Enter the following information for this class action case- the deadline is approaching.

See If you Qualify for Monetary Reward

Loss Submission Form

Submitting your information does not create an attorney-client relationship and you are giving us your express consent to contact you by email, text message, SMS, or call you by telephone.